語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
到查詢結果
[ null ]
切換:
標籤
|
MARC模式
|
ISBD
Molecular Co-Evolution Between SARS-...
~
Moulana, Alief,
FindBook
Google Book
Amazon
博客來
Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies // Alief Moulana.
作者:
Moulana, Alief,
面頁冊數:
1 electronic resource (123 pages)
附註:
Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
Contained By:
Dissertations Abstracts International86-12B.
標題:
Biology. -
電子資源:
https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32040550
ISBN:
9798280717008
Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /
Moulana, Alief,
Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /
Alief Moulana. - 1 electronic resource (123 pages)
Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
The COVID-19 pandemic disrupted global health systems but simultaneously offered a rare opportunity to observe the rapid co-evolution of a virus, SARS-CoV-2, with the human immune system in real time. This evolutionary interplay is often thought of as a molecular arms race, in which both pathogen and host must continually adapt to changes in each other's phenotype. This dynamic is particularly pronounced at the molecular recognition level. Human antibodies evolve (via affinity maturation) to better neutralize the viral antigens (e.g., SARS-CoV-2 spike protein), while the virus, in turn, accumulates mutations that confer immune escape. In this dissertation, I present four projects that explore the co-evolutionary landscape between viral and immune proteins. Chapters 1 and 2 focus on the combinatorial mutagenesis of the SARS-CoV-2 spike receptor-binding domain (RBD) to measure the individual and combined effects of Omicron BA.1 mutations on ACE2 binding affinity (Chapter 1) and antibody evasion (Chapter 2). Chapter 3 extends this approach to later Omicron subvariants, using high-throughput genotype-to-phenotype mapping to investigate how mutational effects depend on genetic background across divergent lineages. Finally, Chapter 4 shifts focus to the host immune response, using deep sequencing of human peripheral blood B cell repertoires and yeast display of candidate antibodies to measure evolving antibody phenotypes. Together, these studies provide an integrated view of viral and immune co-evolution, inferring the molecular principles that govern host-pathogen interactions and the trajectory of viral adaptation.
English
ISBN: 9798280717008Subjects--Topical Terms:
522710
Biology.
Subjects--Index Terms:
B cell
Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /
LDR
:03064nmm a22004333i 4500
001
2433859
005
20250905091029.5
006
m o d
007
cr|nu||||||||
008
261011s2025 miu||||||m |||||||eng d
020
$a
9798280717008
035
$a
(MiAaPQD)AAI32040550
035
$a
AAI32040550
040
$a
MiAaPQD
$b
eng
$c
MiAaPQD
$e
rda
100
1
$a
Moulana, Alief,
$e
author.
$0
(orcid)0000-0002-0389-7082
$3
3823631
245
1 0
$a
Molecular Co-Evolution Between SARS-CoV-2 and Human Antibodies /
$c
Alief Moulana.
264
1
$a
Ann Arbor :
$b
ProQuest Dissertations & Theses,
$c
2025
300
$a
1 electronic resource (123 pages)
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
500
$a
Source: Dissertations Abstracts International, Volume: 86-12, Section: B.
500
$a
Advisors: Desai, Michael Committee members: Chakraborty, Arup; Cavanaugh, Colleen; Edwards, Scott.
502
$b
Ph.D.
$c
Harvard University
$d
2025.
520
$a
The COVID-19 pandemic disrupted global health systems but simultaneously offered a rare opportunity to observe the rapid co-evolution of a virus, SARS-CoV-2, with the human immune system in real time. This evolutionary interplay is often thought of as a molecular arms race, in which both pathogen and host must continually adapt to changes in each other's phenotype. This dynamic is particularly pronounced at the molecular recognition level. Human antibodies evolve (via affinity maturation) to better neutralize the viral antigens (e.g., SARS-CoV-2 spike protein), while the virus, in turn, accumulates mutations that confer immune escape. In this dissertation, I present four projects that explore the co-evolutionary landscape between viral and immune proteins. Chapters 1 and 2 focus on the combinatorial mutagenesis of the SARS-CoV-2 spike receptor-binding domain (RBD) to measure the individual and combined effects of Omicron BA.1 mutations on ACE2 binding affinity (Chapter 1) and antibody evasion (Chapter 2). Chapter 3 extends this approach to later Omicron subvariants, using high-throughput genotype-to-phenotype mapping to investigate how mutational effects depend on genetic background across divergent lineages. Finally, Chapter 4 shifts focus to the host immune response, using deep sequencing of human peripheral blood B cell repertoires and yeast display of candidate antibodies to measure evolving antibody phenotypes. Together, these studies provide an integrated view of viral and immune co-evolution, inferring the molecular principles that govern host-pathogen interactions and the trajectory of viral adaptation.
546
$a
English
590
$a
School code: 0084
650
4
$a
Biology.
$3
522710
650
4
$a
Immunology.
$3
611031
650
4
$a
Virology.
$3
642304
653
$a
B cell
653
$a
Binding affinity
653
$a
Evolution
653
$a
Genotype-to-phenotype map
653
$a
Molecular recognition
690
$a
0306
690
$a
0982
690
$a
0720
710
2
$a
Harvard University.
$b
Biology, Organismic and Evolutionary.
$e
degree granting institution.
$3
3823632
720
1
$a
Desai, Michael
$e
degree supervisor.
773
0
$t
Dissertations Abstracts International
$g
86-12B.
790
$a
0084
791
$a
Ph.D.
792
$a
2025
856
4 0
$u
https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=32040550
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9529554
電子資源
11.線上閱覽_V
電子書
EB
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入
(1)帳號:一般為「身分證號」;外籍生或交換生則為「學號」。 (2)密碼:預設為帳號末四碼。
帳號
.
密碼
.
請在此電腦上記得個人資料
取消
忘記密碼? (請注意!您必須已在系統登記E-mail信箱方能使用。)